Biofrontera (BFRI) Cash & Current Investments (2020 - 2025)
Biofrontera has reported Cash & Current Investments over the past 6 years, most recently at $6.4 million for Q4 2025.
- For Q4 2025, Cash & Current Investments rose 8.41% year-over-year to $6.4 million; the TTM value through Dec 2025 reached $6.4 million, up 8.41%, while the annual FY2025 figure was $6.4 million, 8.41% up from the prior year.
- Cash & Current Investments for Q4 2025 was $6.4 million at Biofrontera, up from $3.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $31.9 million in Q2 2022 and troughed at $1.4 million in Q4 2023.
- A 5-year average of $11.1 million and a median of $6.4 million in 2025 define the central range for Cash & Current Investments.
- Biggest five-year swings in Cash & Current Investments: skyrocketed 1518.71% in 2022 and later plummeted 94.88% in 2023.
- Year by year, Cash & Current Investments stood at $24.5 million in 2021, then rose by 13.05% to $27.7 million in 2022, then plummeted by 94.88% to $1.4 million in 2023, then surged by 316.05% to $5.9 million in 2024, then increased by 8.41% to $6.4 million in 2025.
- Business Quant data shows Cash & Current Investments for BFRI at $6.4 million in Q4 2025, $3.4 million in Q3 2025, and $7.2 million in Q2 2025.